Alberto Reiner

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Apr Applied Pharma Research Sa, Crinos Industria Farmacobiologica S.p.a., D and D S.r.l.. Active years: 1979-2025.

USPTO Granted Patents = 34 (Patent Applications = 9)

% Patents Active = 85.3

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 173(Granted Patents)

Company Filing History:

16 out of 26

Apr Applied Pharma Research Sa

patents

2 out of 35

Crinos Industria Farmacobiologica S.p.a.

Kowa Pharmaceuticals America, Inc.

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

patents

8. 1 out of 1

Crinos Farmacologica Spa

patent

9. 1 out of 88

Fidia Farmaceutici S.p.a.

Kowa Pharmaeuticals America, Inc.

patent

12. 1 out of 1

Laboratori Prophin S.p.a.

Proethic Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 1979-2025

Loading Chart...

Areas of Expertise:

Diclofenac

Amino Acids

Pharmaceutical Compositions

Bioavailable Formulations

Blister Packaging

Analgesic Treatments

Granulates

Ursodeoxycholic Acid

Therapeutically Active Derivatives

Zero-Order Release

Water Soluble Derivatives

Pyridoxine

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440463 - Modified release orally administered amino acid formulations (2025-10-14),

2. 12036317 - Ready to use diclofenac stick packs (2024-07-16),

3. 11701335 - Methods of normalizing amino acid metabolism (2023-07-18),

4. 11419837 - Modified release orally administered amino acid formulations (2022-08-23),

5. 11260026 - Ready to use diclofenac stick packs (2022-03-01),

6. 11123318 - Substantially sodium free diclofenac potassium oral solutions (2021-09-21),

7. 10500180 - Modified release orally administered amino acid formulations (2019-12-10),

8. 9827197 - Diclofenac formulations and methods of use (2017-11-28),

9. 8927604 - Diclofenac formulations and methods of use (2015-01-06),

10. 8097651 - Diclofenac formulations and methods of use (2012-01-17),

11. 8097267 - Moisture resistant container systems for rapidly bioavailable dosage forms (2012-01-17),

12. 8039024 - Device and composition for the delivery of a preservative-free balsamic cream (2011-10-18),

13. 7939561 - Blister packaging for acute pain regimens (2011-05-10),

14. 7759394 - Diclofenac formulations and methods of use (2010-07-20),

15. 7700125 - Moisture resistant container systems for rapidly bioavailable dosage forms (2010-04-20),

Title: **Alberto Reiner: Innovator in Pharmaceutical Formulations**

Introduction

Alberto Reiner is a prominent inventor based in Como, Italy, recognized for his significant contributions to the field of pharmaceuticals. With an impressive record of 33 patents, he has played a vital role in advancing medication formulations and methods, particularly in the treatment of pain and amino acid metabolism.

Latest Patents

Among his latest innovations, Reiner has developed ready-to-use diclofenac stick packs, which include liquid formulations of diclofenac potassium that are especially suited for packaging in stick-packs. Additionally, he has introduced methods for normalizing amino acid metabolism in individuals on restricted protein diets, utilizing specially formulated amino acids that mimic the natural absorption and metabolism processes of proteins. These advancements are critical for enhancing the efficacy of treatments in a clinical setting.

Career Highlights

Throughout his career, Reiner has been associated with notable pharmaceutical companies, including Apr Applied Pharma Research SA and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. His work with these organizations has not only contributed to his personal patent portfolio but has also impacted the broader landscape of pharmaceutical development.

Collaborations

Reiner has collaborated with esteemed professionals, including Giorgio Reiner and Andreas Meyer. These partnerships reflect his commitment to teamwork and innovation within the industry, fostering advancements that benefit healthcare.

Conclusion

Alberto Reiner's dedication to innovation in pharmaceutical formulations exemplifies the vital role that inventors play in enhancing medical treatments. With a strong patent portfolio and successful collaborations, he continues to influence the future of healthcare and therapeutic solutions.